PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Stürzebecher, P.E.* ; Kralisch, S.* ; Schubert, M.R.* ; Filipova, V.* ; Hoffmann, A.* ; Oliveira, F. ; Sheikh, B. ; Blüher, M. ; Kogel, A.* ; Scholz, M.* ; Kokot, K.E.* ; Erbe, S.* ; Kneuer, J.M.* ; Ebert, T.* ; Fasshauer, M.* ; Miehle, K.* ; Laufs, U.* ; Tönjes, A.* ; Boeckel, J.N.*

Leptin treatment has vasculo-protective effects in lipodystrophic mice.

Proc. Natl. Acad. Sci. U.S.A. 119:e2110374119 (2022)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Lipodystrophy syndromes (LDs) are characterized by loss of adipose tissue, metabolic complications such as dyslipidemia, insulin resistance, and fatty liver disease, as well as accelerated atherosclerosis. As a result of adipose tissue deficiency, the systemic concentration of the adipokine leptin is reduced. A current promising therapeutic option for patients with LD is treatment with recombinant leptin (metreleptin), resulting in reduced risk of mortality. Here, we investigate the effects of leptin on endothelial to mesenchymal transition (EndMT), which impair the functional properties of endothelial cells and promotes atherogenesis in LD. Leptin treatment reduced inflammation and TGF-β2-induced expression of mesenchymal genes and prevented impairment of endothelial barrier function. Treatment of lipodystrophic- and atherosclerosis-prone animals (Ldlr-/-; aP2-nSrebp1c-Tg) with leptin reduced macrophage accumulation in atherosclerotic lesions, vascular plaque protrusion, and the number of endothelial cells with mesenchymal gene expression, confirming a reduction in EndMT in LD after leptin treatment. Treatment with leptin inhibited LD-mediated induction of the proatherosclerotic cytokine growth/differentiation factor 15 (GDF15). Inhibition of GDF15 reduced EndMT induction triggered by plasma from patients with LD. Our study reveals that in addition to the effects on adipose tissue function, leptin treatment exerts beneficial effects protecting endothelial function and identity in LD by reducing GDF15.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
12.779
0.000
5
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Atherosclerosis ; Endmt ; Gdf15 ; Leptin ; Lipodystrophy; To-mesenchymal Transition; Insulin-resistance; Adipose-tissue; Aortic-arch; Atherosclerotic Plaque; Diabetes-mellitus; Obesity; Atheromas; Risk; Endothelin-1
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
ISSN (print) / ISBN 0027-8424
e-ISSN 1091-6490
Zeitschrift Proceedings of the National Academy of Sciences of the United States of America
Quellenangaben Band: 119, Heft: 40, Seiten: , Artikelnummer: e2110374119 Supplement: ,
Verlag National Academy of Sciences
Verlagsort 2101 Constitution Ave Nw, Washington, Dc 20418 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-555000-001
G-506501-001
Förderungen German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)
DOI 10.1073/pnas.2110374119
WOS ID 001009398200001
Scopus ID 85138648490
PubMed ID 36161905
Erfassungsdatum 2022-10-13
[➜Korrektur melden]